CIK 0000872912
- Non-accelerated filer
- Smaller reporting company
DELCATH SYSTEMS, INC.
Sign in to watch- Ticker
- DCTH
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 061245881
- Phone
- +1 518-743-8892
- Business address
- 566 QUEENSBURY AVENUE, QUEENSBURY, NY, 12804
- Former names
- DELCATH SYSTEMS, INC., DELCATH SYSTEMS INC
- 4 Grant or award GM INTERVENTIONAL ONCOLOGY acquired 13,441 shares (grant or award)
- 4 Grant or award GEN'L COUNSEL, CCO & SECY acquired 20,161 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Medical Officer bought 40,000 shares at $3.00 ($120,000)
- 4 Open-market buy Chief Executive Officer bought 34,000 shares at $2.94 ($99,960)
- 4 Open-market buy Director bought 100,000 shares at $2.40 ($240,410)
- 4 Open-market buy SVP of Finance, PFO and PAO bought 30,000 shares at $2.43 ($72,900)
- 4 Open-market buy Chief Medical Officer bought 60,000 shares at $2.48 ($148,800)
- 4 Open-market buy See Remarks bought 40,000 shares at $2.48 ($99,200)
- 4 Open-market buy Chief Operating Officer bought 14,505 shares at $3.44 ($49,897)
Page 4 of 30 · 595 filings